Delivery Order SPE2DB24D3014-SPE2DB26FKRXG
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $23,260.35 delivery order on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This is a firm fixed-price, non-set-aside contract with performance through November 5, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,445.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,949.85 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,907.40 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This is a firm fixed price delivery order with no set-aside designation, executed under a competitive award process. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,945.20 delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery is scheduled for completion by July 10, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a $3,003.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This competitive award, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $9,639.11 with an ultimate completion date of October 29, 2025. This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical product will be...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB26FKRXGDelivery Order
The Defense Logistics Agency awarded a $3,158.88 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-set-aside, firm fixed-price contract is scheduled for completion by November 6, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Health Agency and other government healthcare systems through its comprehensive pharmaceutical supply agreement with the Defense Logistics Agency. The contract exemplifies the agency's medical supply chain operations, which leverage AmerisourceBergen's extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare programs worldwide. As a competitively awarded contractor, AmerisourceBergen demonstrates its capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/5/25 |